Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial

NCT02181101 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3754

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: FEC-DocGemzar adjuvant chemotherapy
DRUG: FEC-Doc adjuvant chemotherapy
DRUG: Zoledronic acid i.v. 2 years
DRUG: Zoledronic acid i.v. 5 years

Sponsor

Ludwig-Maximilians - University of Munich

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]